Short answer · Medically reviewed summary · Last updated: 2026-04-07
The International Classification of Diseases, 10th Revision (ICD-10) code for Prader-Willi Syndrome is Q87.1, while the older ICD-9 code for the condition is 759.81. These diagnostic codes are used globally by healthcare providers and insurance systems to identify and document Prader-Willi Syndrome in medical records. What is the clinical significance of the ICD codes for Prader-Willi Syndrome? The ICD-10 code Q87.1 is categorized under "Congenital malformation syndromes predominantly associated with short stature." For families navigating the healthcare system, the correct documentation of Prader-Willi Syndrome is essential for accessing specialized services, including growth hormone therapy, nutritional management, and behavioral health support.
The International Classification of Diseases, 10th Revision (ICD-10) code for Prader-Willi Syndrome is Q87.1, while the older ICD-9 code for the condition is 759.81. These diagnostic codes are used globally by healthcare providers and insurance systems to identify and document Prader-Willi Syndrome in medical records.
The ICD-10 code Q87.1 is categorized under "Congenital malformation syndromes predominantly associated with short stature." For families navigating the healthcare system, the correct documentation of Prader-Willi Syndrome is essential for accessing specialized services, including growth hormone therapy, nutritional management, and behavioral health support. While the ICD-9 code 759.81 is now retired, it remains present in older medical charts and historical research data, which is important to note if you are reviewing long-term medical records for a loved one with Prader-Willi Syndrome.
Prader-Willi Syndrome is a complex multisystem genetic disorder caused by the loss of function of specific genes on the paternal copy of chromosome 15 (15q11-q13). The clinical presentation of Prader-Willi Syndrome typically shifts over time, often beginning with profound hypotonia (low muscle tone) and feeding difficulties in infancy, followed by the development of hyperphagia (an insatiable appetite) and cognitive delays in early childhood. Managing the symptoms of Prader-Willi Syndrome requires a multidisciplinary team approach to address the unique metabolic, endocrine, and behavioral challenges that patients face throughout their lifespan.
Diagnosis is primarily established through molecular genetic testing rather than clinical observation alone. Because Prader-Willi Syndrome can arise from three different genetic mechanisms—paternal deletion (approximately 70%), maternal uniparental disomy (approximately 25%), or an imprinting defect (approximately 5%)—a specific DNA methylation analysis is the gold standard for diagnosis. Current medical literature emphasizes that early testing is critical for timely intervention. At DiseaseMaps.org, 241 people with Prader-Willi Syndrome have joined our community, sharing their diagnostic journeys and lived experiences with families worldwide.
Effective care for Prader-Willi Syndrome involves proactive management of the following areas:
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.